Cargando…
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm
Neither the disease mechanism nor treatments for COVID-19 are currently known. Here, we present a novel molecular mechanism for COVID-19 that provides therapeutic intervention points that can be addressed with existing FDA-approved pharmaceuticals. The entry point for the virus is ACE2, which is a c...
Autores principales: | Garvin, Michael R, Alvarez, Christiane, Miller, J Izaak, Prates, Erica T, Walker, Angelica M, Amos, B Kirtley, Mast, Alan E, Justice, Amy, Aronow, Bruce, Jacobson, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410499/ https://www.ncbi.nlm.nih.gov/pubmed/32633718 http://dx.doi.org/10.7554/eLife.59177 |
Ejemplares similares
-
Response to comment on ‘SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung’
por: Mast, Alan E, et al.
Publicado: (2022) -
SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung
por: Mast, Alan E, et al.
Publicado: (2021) -
Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2
por: Prates, Erica T, et al.
Publicado: (2020) -
A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications
por: McCarthy, Cameron G., et al.
Publicado: (2021) -
Between two storms, vasoactive peptides or bradykinin underlie severity of COVID‐19?
por: Karamyan, Vardan T.
Publicado: (2021)